Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

No magic pill for treating dementia symptoms

02.02.2005


Many of the drugs commonly prescribed to treat agitation, delusions and other symptoms that can accompany dementia are not effective, researchers from Wake Forest University Baptist Medical Center and colleagues report this week in the Journal of the American Medical Association.



"Our review of 29 research studies found that drug therapies are not particularly effective for managing symptoms such as agitation, wandering and delusions that are observed in most patients with dementia at some point in the illness," said Kaycee Sink, M.D., lead researcher. "There is no clear standard of care, and treatment is often based on local prescribing customs."

While the primary symptoms of Alzheimer’s disease and other forms of dementia involve memory deficits, other symptoms, including agitation, aggression, delusions, hallucinations, repetitive vocalizations and wandering have been observed in 60 percent to 98 percent of patients. "Dementia-related behaviors are very distressing to both caregivers and medical professionals," said Sink, a geriatrician. "It was discouraging to find that we currently don’t have good drug therapies for them."


More than half of people over age 85 are affected by dementia. Dementia-related behavioral problems are associated with longer hospital stays and often lead to placement in a nursing home. About 30 percent of the cost of caring for patients with Alzheimer’s disease is attributed to managing these symptoms, Sink said.

Sink and colleagues, Karen F. Holden, M.D., and Kristine Yaffe, M.D., both from the University of California at San Francisco, reviewed 29 research studies published between 1966 and mid-2004 that involved drug therapy commonly used for patients with dementia-related behaviors.

The study was designed to evaluate the effectiveness of current treatments for these behaviors and provide physicians with an evidence-based assessment of treatment options. The researchers analyzed data from studies evaluating more than 15 drugs that are commonly prescribed for dementia symptoms, including antipsychotics, antidepressants and mood stabilizers. They found that two drugs (risperidone and olanzapine) in a class known as atypical antipsychotics have the best evidence for effectiveness. "However, the effects are modest and are complicated by an increased risk of stroke," the authors write. "Physicians considering prescribing these drugs should discuss the potential risks and benefits with patients and their caregivers."

Because federal expenditures for dementia are expected to triple in the next 10 years, the authors said it is essential to find more effective treatments. They said non-drug therapies should always be considered first, and that some small studies have shown that music therapy, aromatherapy, pet therapy and caregiver education may be effective. "Larger, well-designed controlled trials of non-drug interventions are needed," said Sink, an assistant professor of internal medicine – geriatrics.

The authors said that additional studies of drug therapy are also needed and that a large multi-center center study now under way to compare four atypical antipsychotic drugs will be particularly valuable.

Karen Richardson | EurekAlert!
Further information:
http://www.wfubmc.edu

More articles from Health and Medicine:

nachricht Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht FAU researchers demonstrate that an oxygen sensor in the body reduces inflammation
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Newly designed molecule binds nitrogen

23.02.2018 | Life Sciences

Stagnation in the South Pacific Explains Natural CO2 Fluctuations

23.02.2018 | Earth Sciences

Mat4Rail: EU Research Project on the Railway of the Future

23.02.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>